INTRODUCTION: Evidence strongly suggests that soluble oligomers of amyloid beta protein (oAβ) help initiate the pathogenic cascade of Alzheimer's disease (AD). To date, there have been no validated assays specific for detecting and quantifying oAβ in human blood. METHODS: We developed an ultrasensitive oAβ immunoassay using a novel capture antibody (71A1) with N-terminal antibody 3D6 for detection that specifically quantifies soluble oAβ in the human brain, cerebrospinal fluid (CSF), and plasma. RESULTS: Two new antibodies (71A1; 1G5) are oAβ-selective, label Aβ plaques in non-fixed AD brain sections, and potently neutralize the synaptotoxicity of AD brain-derived oAβ. The 71A1/3D6 assay showed excellent dilution linearity in CSF and plasma without matrix effects, good spike recovery, and specific immunodepletion. DISCUSSION: We have created a sensitive, high throughput, and inexpensive method to quantify synaptotoxic oAβ in human plasma for analyzing large cohorts of aged and AD subjects to assess the dynamics of this key pathogenic species and response to therapy.
INTRODUCTION: Evidence strongly suggests that soluble oligomers of amyloid beta protein (oAβ) help initiate the pathogenic cascade of Alzheimer's disease (AD). To date, there have been no validated assays specific for detecting and quantifying oAβ in human blood. METHODS: We developed an ultrasensitive oAβ immunoassay using a novel capture antibody (71A1) with N-terminal antibody 3D6 for detection that specifically quantifies soluble oAβ in the human brain, cerebrospinal fluid (CSF), and plasma. RESULTS: Two new antibodies (71A1; 1G5) are oAβ-selective, label Aβ plaques in non-fixed AD brain sections, and potently neutralize the synaptotoxicity of AD brain-derived oAβ. The 71A1/3D6 assay showed excellent dilution linearity in CSF and plasma without matrix effects, good spike recovery, and specific immunodepletion. DISCUSSION: We have created a sensitive, high throughput, and inexpensive method to quantify synaptotoxic oAβ in human plasma for analyzing large cohorts of aged and AD subjects to assess the dynamics of this key pathogenic species and response to therapy.
Authors: C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters Journal: Ann Neurol Date: 1999-12 Impact factor: 10.422
Authors: Mary P Lambert; Pauline T Velasco; Lei Chang; Kirsten L Viola; Sara Fernandez; Pascale N Lacor; Daliya Khuon; Yuesong Gong; Eileen H Bigio; Pamela Shaw; Fernanda G De Felice; Grant A Krafft; William L Klein Journal: J Neurochem Date: 2006-11-20 Impact factor: 5.372
Authors: Robert M Koffie; Melanie Meyer-Luehmann; Tadafumi Hashimoto; Kenneth W Adams; Matthew L Mielke; Monica Garcia-Alloza; Kristina D Micheva; Stephen J Smith; M Leo Kim; Virginia M Lee; Bradley T Hyman; Tara L Spires-Jones Journal: Proc Natl Acad Sci U S A Date: 2009-02-19 Impact factor: 11.205
Authors: Isabel Morgado; Karin Wieligmann; Magdalena Bereza; Raik Rönicke; Katrin Meinhardt; Karthikeyan Annamalai; Monika Baumann; Jessica Wacker; Peter Hortschansky; Miroslav Malešević; Christoph Parthier; Christian Mawrin; Cordelia Schiene-Fischer; Klaus G Reymann; Milton T Stubbs; Jochen Balbach; Matthias Görlach; Uwe Horn; Marcus Fändrich Journal: Proc Natl Acad Sci U S A Date: 2012-07-18 Impact factor: 11.205
Authors: M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein Journal: Proc Natl Acad Sci U S A Date: 1998-05-26 Impact factor: 11.205
Authors: R C Petersen; R O Roberts; D S Knopman; Y E Geda; R H Cha; V S Pankratz; B F Boeve; E G Tangalos; R J Ivnik; W A Rocca Journal: Neurology Date: 2010-09-07 Impact factor: 9.910
Authors: Elisabeth H Thijssen; Renaud La Joie; Amy Wolf; Amelia Strom; Ping Wang; Leonardo Iaccarino; Viktoriya Bourakova; Yann Cobigo; Hilary Heuer; Salvatore Spina; Lawren VandeVrede; Xiyun Chai; Nicholas K Proctor; David C Airey; Sergey Shcherbinin; Cynthia Duggan Evans; John R Sims; Henrik Zetterberg; Kaj Blennow; Anna M Karydas; Charlotte E Teunissen; Joel H Kramer; Lea T Grinberg; William W Seeley; Howie Rosen; Bradley F Boeve; Bruce L Miller; Gil D Rabinovici; Jeffrey L Dage; Julio C Rojas; Adam L Boxer Journal: Nat Med Date: 2020-03-02 Impact factor: 53.440
Authors: Yi-Chen Hsieh; Joseph Negri; Amy He; Richard V Pearse; Lei Liu; Duc M Duong; Lori B Chibnik; David A Bennett; Nicholas T Seyfried; Tracy L Young-Pearse Journal: Mol Neurodegener Date: 2022-09-21 Impact factor: 18.879